M

Medipost Co Ltd
KOSDAQ:078160

Watchlist Manager
Medipost Co Ltd
KOSDAQ:078160
Watchlist
Price: 23 900 KRW 1.92%
Market Cap: ₩936.9B

Operating Margin

-89%
Current
Declining
by 39.1%
vs 3-y average of -49.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-89%
=
Operating Income
₩-65.5B
/
Revenue
₩73.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-89%
=
Operating Income
₩-65.5B
/
Revenue
₩73.6B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Medipost Co Ltd
KOSDAQ:078160
934.1B KRW
Loading...
US
CVS Health Corp
NYSE:CVS
93.3B USD
Loading...
US
Cigna Group
XMUN:CGN
60.5B EUR
Loading...
US
Cigna Corp
NYSE:CI
72.3B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.9B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.9B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.4B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.3B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
10.9B AUD
Loading...

Market Distribution

Lower than 95% of companies in Korea
Percentile
5th
Based on 2 615 companies
5th percentile
-89%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Medipost Co Ltd
Glance View

Market Cap
936.9B KRW
Industry
Health Care

Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2005-07-29. The firm mainly operates cord blood banks. Its cord blood banks consist of public cord blood bank, which provides resource to anyone who may need to undergo hematopoietic stem cell transplantation (HSCT) as a result of blood-related diseases, such as leukemia or aplastic anemia, as well as family cord blood bank, which provides services for storing newborn’s cord blood exclusively for family’s use. The company also involves in the provision of stem cell drugs, which are used for recovery of knee articular cartilage and others, distribution of healthcare food and natural cosmetics, as well as provision of healthcare services.

Medipost Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-89%
=
Operating Income
₩-65.5B
/
Revenue
₩73.6B
What is Medipost Co Ltd's current Operating Margin?

The current Operating Margin for Medipost Co Ltd is -89%, which is below its 3-year median of -49.9%.

How has Operating Margin changed over time?

Over the last 3 years, Medipost Co Ltd’s Operating Margin has decreased from -25.4% to -89%. During this period, it reached a low of -102.6% on Mar 31, 2025 and a high of 5% on Mar 31, 2024.

Back to Top